Illumina | ILMN - Net Income


Illumina reported $150M in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
Agilent USD 434M 98M Sep/2025
Bio Techne USD 38.01M 176K Dec/2025
Bio-Rad Laboratories USD 317.8M 253.8M Jun/2025
Boston Scientific USD 672M 83M Dec/2025
Bruker USD -62.4M 70M Sep/2025
Charles River Laboratories USD 54.42M 2.1M Sep/2025
Danaher USD 1.2B 289M Dec/2025
Dentsply International USD -427M 382M Sep/2025
Edwards Lifesciences USD 291.1M 42.1M Sep/2025
Exact Sciences USD -19.59M 18.41M Sep/2025
Hologic USD 179.1M 8.2M Dec/2025
Illumina USD 150M 85M Sep/2025
Intuitive Surgical USD 794.8M 90.4M Dec/2025
IQVIA Holdings USD 331M 65M Sep/2025
Laboratory Of America USD 261.1M 23.2M Sep/2025
Mettler Toledo International USD 217.49M 15.14M Sep/2025
Myriad Genetics USD -27.4M 303.1M Sep/2025
Quest Diagnostics USD 245M 37M Sep/2025
Quidel USD -733M 477.6M Sep/2025
Repligen USD 14.91M 44K Sep/2025
Revvity USD 46.65M 7.3M Sep/2025
Roche Holding CHF 5.47B 1.76B Dec/2025
Standard Biotools USD -34.69M 1.23M Sep/2025
Thermo Fisher Scientific USD 1.96B 348M Dec/2025
Waters USD 148.92M 1.81M Sep/2025